117 related articles for article (PubMed ID: 7559211)
1. Circulating endothelin-1 reduces splanchnic and renal blood flow and splanchnic glucose production in humans.
Ahlborg G; Weitzberg E; Lundberg JM
J Appl Physiol (1985); 1995 Jul; 79(1):141-5. PubMed ID: 7559211
[TBL] [Abstract][Full Text] [Related]
2. ET-3 is extracted by and induces potent vasoconstriction in human splanchnic and renal vasculatures.
Weitzberg E; Hemsén A; Lundberg JM; Ahlborg G
J Appl Physiol (1985); 1995 Oct; 79(4):1255-9. PubMed ID: 8567570
[TBL] [Abstract][Full Text] [Related]
3. Big ET-1 infusion in man causes renal ET-1 release, renal and splanchnic vasoconstriction, and increased mean arterial blood pressure.
Ahlborg G; Ottosson-Seeberger A; Hemsén A; Lundberg JM
Cardiovasc Res; 1994 Oct; 28(10):1559-63. PubMed ID: 8001046
[TBL] [Abstract][Full Text] [Related]
4. Metabolic and vascular effects of circulating endothelin-1 during moderately heavy prolonged exercise.
Ahlborg G; Weitzberg E; Lundberg J
J Appl Physiol (1985); 1995 Jun; 78(6):2294-300. PubMed ID: 7665432
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 infusion reduces splanchnic glucose production in humans.
Ahlborg G; Weitzberg E; Lundberg JM
J Appl Physiol (1985); 1994 Jul; 77(1):121-6. PubMed ID: 7961223
[TBL] [Abstract][Full Text] [Related]
6. Long-lasting vasoconstriction and efficient regional extraction of endothelin-1 in human splanchnic and renal tissues.
Weitzberg E; Ahlborg G; Lundberg JM
Biochem Biophys Res Commun; 1991 Nov; 180(3):1298-303. PubMed ID: 1953780
[TBL] [Abstract][Full Text] [Related]
7. Splanchnic and renal vasoconstrictor and metabolic responses to neuropeptide Y in resting and exercising man.
Ahlborg G; Weitzberg E; Sollevi A; Lundberg JM
Acta Physiol Scand; 1992 Jun; 145(2):139-49. PubMed ID: 1636443
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase inhibition potentiates the renal vascular response to endothelin-1 in humans.
Ahlborg G; Lundberg JM
J Appl Physiol (1985); 1998 Nov; 85(5):1661-6. PubMed ID: 9804567
[TBL] [Abstract][Full Text] [Related]
9. Insulin sensitivity and big ET-1 conversion to ET-1 after ETA- or ETB-receptor blockade in humans.
Ahlborg G; Lindström J
J Appl Physiol (1985); 2002 Dec; 93(6):2112-21. PubMed ID: 12391119
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide-endothelin-1 interaction in humans.
Ahlborg G; Lundberg JM
J Appl Physiol (1985); 1997 May; 82(5):1593-600. PubMed ID: 9134909
[TBL] [Abstract][Full Text] [Related]
11. Regional effects and clearance of endothelin-1 across pulmonary and splanchnic circulation.
Wagner OF; Vierhapper H; Gasic S; Nowotny P; Waldhäusl W
Eur J Clin Invest; 1992 Apr; 22(4):277-82. PubMed ID: 1499643
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic effects of endothelin-1 and big endothelin-1 in chronic hemodialysis patients.
Ottosson-Seeberger A; Ahlborg G; Hemsén A; Lundberg JM; Alvestrand A
J Am Soc Nephrol; 1999 May; 10(5):1037-44. PubMed ID: 10232690
[TBL] [Abstract][Full Text] [Related]
13. The C-terminal fragment of big endothelin-1 does not potentiate the vasoactive effects of endothelin-1.
Ottosson-Seeberger A; Hemsén A; Lundberg JM; Ahlborg G
Clin Physiol; 1998 Jan; 18(1):61-8. PubMed ID: 9545622
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 and -3 plasma concentrations in patients with cirrhosis: role of splanchnic and renal passage and liver function.
Gerbes AL; Møller S; Gülberg V; Henriksen JH
Hepatology; 1995 Mar; 21(3):735-9. PubMed ID: 7875671
[TBL] [Abstract][Full Text] [Related]
15. Splanchnic and renal vasoconstriction during neuropeptide Y infusion in healthy humans.
Ahlborg G; Weitzberg E; Lundberg JM
Clin Physiol; 1992 Mar; 12(2):145-53. PubMed ID: 1582134
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of neuropeptide Y on splanchnic glycogenolysis and renin release in humans.
Ahlborg G; Lundberg JM
Clin Physiol; 1994 Mar; 14(2):187-96. PubMed ID: 8205750
[TBL] [Abstract][Full Text] [Related]
17. Circulatory responses to endothelin-1 and nitric oxide with special reference to endotoxin shock and nitric oxide inhalation.
Weitzberg E
Acta Physiol Scand Suppl; 1993; 611():1-72. PubMed ID: 8379340
[TBL] [Abstract][Full Text] [Related]
18. Splanchnic vasomotor and metabolic adjustments to hypoxia and exercise in humans.
Rowell LB; Blackmon JR; Kenny MA; Escourrou P
Am J Physiol; 1984 Aug; 247(2 Pt 2):H251-8. PubMed ID: 6465330
[TBL] [Abstract][Full Text] [Related]
19. Central and regional hemodynamic effects during infusion of Big endothelin-1 in healthy humans.
Ahlborg G; Ottosson-Seeberger A; Hemsén A; Lundberg JM
J Appl Physiol (1985); 1996 Jun; 80(6):1921-7. PubMed ID: 8806895
[TBL] [Abstract][Full Text] [Related]
20. Direct assessment of splanchnic uptake and metabolic effects of human and porcine insulin.
Saccà L; Orofino G; Petrone A; Vigorito C
J Clin Endocrinol Metab; 1984 Aug; 59(2):191-6. PubMed ID: 6145721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
